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ABSTRACT
Mer1p activates the splicing of at least three
pre-mRNAs (AMA1, MER2, MER3) during meiosis in
the yeast Saccharomyces cerevisiae. We demonstrate that enhancer recognition by Mer1p is separable from Mer1p splicing activation. The C-terminal
KH-type RNA-binding domain of Mer1p recognizes
introns that contain the Mer1p splicing enhancer,
while the N-terminal domain interacts with the
spliceosome and activates splicing. Prior studies
have implicated the U1 snRNP and recognition of
the 5¢ splice site as key elements in Mer1p-activated
splicing. We provide new evidence that Mer1p
may also function at later steps of spliceosome
assembly. First, Mer1p can activate splicing of
introns that have mutated branch point sequences.
Secondly, Mer1p fails to activate splicing in the
absence of the non-essential U2 snRNP protein
Snu17p. Thirdly, Mer1p interacts with the branch
point binding proteins Mud2p and Bbp1p and the U2
snRNP protein Prp11p by two-hybrid assays. We
conclude that Mer1p is a modular splicing regulator
that can activate splicing at several early steps of
spliceosome assembly and depends on the activities of both U1 and U2 snRNP proteins to activate
splicing.

INTRODUCTION
Precursor messenger RNAs (pre-mRNAs) in eukaryotes
contain intervening sequences or introns that must be removed
to create a functional RNA. The process of removing introns,
or splicing, occurs in the nucleus and is catalyzed by a large
ribonucleoprotein complex called the spliceosome (reviewed
in 1). In many eukaryotes, especially higher eukaryotes, the
primary transcripts can be alternatively spliced, leading to the
production of functionally diverse protein isoforms (2).
During alternative splicing, splicing regulators modulate the
activity of the spliceosome to alter the selection of splice sites
to be used by either recruiting components of the spliceosome

to the alternative splice sites or blocking the spliceosome from
choosing the default splice sites (3±7).
The action of splicing regulators suggests that formation of
the earliest splicing complex, the commitment complex 1
(CC1) in yeast or the E complex in metazoans, represents an
important control point for splicing regulation. This complex
involves base pairing between the 5¢ splice site and the 5¢ end
of U1 snRNA (8,9) as well as a multitude of U1 snRNP
protein±intron interactions (10,11). With the assistance of the
accessory factors Bbp1p/SF1 and Mud2p/U2AF, commitment
complex 2 (CC2) forms and initially identi®es the branch
point sequence (BPS) which will react with the 5¢ splice site
during the ®rst chemical step of splicing (12±15). However,
splice site selection is not always ®nalized at this stage and can
be altered (16,17). Following CC2 or E complex formation,
the U2 snRNP can bind to form the pre-spliceosome or A
complex. Pre-spliceosome formation requires ATP, and the
intron BPS is recognized by base pairing to U2 snRNA (18±
20). Precisely how U1 and U2 interact with each other in these
early complexes remains unclear. Subsequent spliceosome
assembly events lead to replacement of U1 by U6 at the 5¢
splice site and generation of the catalytic form of the
spliceosome (21).
The mechanisms by which splicing regulators control
splicing complex formation are understood only in the most
simple terms. Both positive and negative splicing regulators
seem to be modular, selecting transcripts for regulation
through their RNA-binding domains, and exerting their action
through their auxiliary domains (7). The nature of the function
of the auxiliary domains remains mysterious. On the basis of
`tethering' experiments in which the activation domain of
the splicing factor is fused to a heterologous RNA-binding
domain and tested for the ability to control splicing of a
transcript containing a heterologous RNA-binding site, it has
been concluded that activation domains regulate the association of snRNPs on nearby regions of the transcript during the
early steps of spliceosome assembly. By regulation of early
snRNP±pre-mRNA interactions, splicing is regulated (22±26).
Several regulators appear to act at later stages of the splicing
pathway, including modulation of spliceosome function rather
than assembly (27). Thus, the speci®c mechanisms by which
splicing activation domains function are of continuing interest.
Mer1p is a splicing regulator that is produced during
meiosis in the yeast Saccharomyces cerevisiae (28). It has a
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MATERIALS AND METHODS
Strains and plasmids
The construction of many of the plasmids used for splicing
analysis in this study were described before (30). The
MS2 Coat gene was ampli®ed from pCT119 (a gift from
D. S. Peabody) by PCR using Vent DNA polymerase and
appropriate primers containing unique restriction enzyme
sites. The MS2 Coat DNA was ligated into pGAC14 plasmid
[2m, TRP1, MS2 Coat transcription under control of the GPD
promoter (33)] between the BamHI and SalI sites to form
pGCOAT. The MS2 Coat gene was also ampli®ed using a
primer that deleted the stop codon and added a hexaglycine
linker to the C-terminus. This fragment was then ligated into
pGMER1 to form pGCTMER1, producing a single ORF for an
N-MS2 Coat-6gly-Mer1-C fusion protein. To construct the
MS2 Coat-Mer1p fusion lacking the KH domain, ®rst the
N-terminal 180 codons of MER1 were ampli®ed by PCR and
ligated into pGAC14 to form pGAD (activation domain). The
MS2 Coat-6gly PCR product was then ligated into pGAD to
form pGCTAD for the expression of the MS2 Coat-6glyMer1p activation domain fusion protein. The resulting
polypeptides coded by the above plasmids were found to be
expressed and stable in yeast extracts when assayed by
western analysis using a polyclonal antibody raised against
Mer1p (data not shown). KH46 (Mata, ura3-52, leu2-3, 112,
trp1-1, lys2, his3-1, ade2-101, cup1D::ura-3±52) yeast were
used for these studies and for isolating total RNA for primer
extension analysis with one exception: the snu17D strain was
purchased from Invitrogen.
The Kunkel method of site-speci®c in vitro mutagenesis
(34) was used to construct pRS316CUP-AMA1bp. This
plasmid carries the Mer1p-activated AMA1/SPO70 intron
fused to CUP1, but the UACUAAC intron BPS is changed to
UAUUAAC. The same method was also used to construct
pRS316CUP-MS2.1ACT G5A. This plasmid uses the GPD
promoter for transcription of an actin pre-mRNA that has a

Figure 1. (A) Mer1p domains and fusion constructs used in this study.
Mer1p contains a C-terminal KH domain RNA-binding motif and an
N-terminal domain required for activating splicing. CTMER has the MS2
Coat gene fused to the N-terminus of the entire MER1 gene, whereas CTAD
has the MS2 Coat gene fused to the activation domain fragment of MER1.
The MS2 Coat construct serves as a control that produces unfused MS2
Coat protein. The AD construct codes for the N-terminal activation domain
from MER1, and the KH construct codes for the C-terminal fragment of
Mer1p which contains the KH domain and short C-terminal peptide. (B) The
sequences of the MS2 operator and MER1 splicing enhancer elements used
to modify the actin intron.

GUAUGU to GUAUAU mutation (G5A) in the 5¢ splice site
sequence, an MS2 operator located 35 nt downstream from the
5¢ splice site, and the CUP1 ORF fused to exon 2 of actin. A
tighter binding variant of the MS2 operator (35) was utilized,
and the sequence of the stem was altered to abolish a cryptic 5¢
splice site that is contained within the wild-type stem sequence
(CGTACaCCaucaGGGTACG, upper case letters form the
stem, lower case letters in the loop or bulge). The new
sequence (CCTAGaCCaucaGGCTAGG) maintained the same
overall secondary structure base pairing potential as the wildtype (Fig. 1).
Primer extension analysis was described before (30) and
performed on duplicate or triplicate samples. Primer extension
products representing spliced and unspliced RNAs were
quantitated by phosphorimaging. The formula S/(S + U),
where S is spliced product and U is unspliced pre-mRNA, was
used to calculate splicing ef®ciency. Primer sequences were
speci®c for plasmid-encoded mRNA and bind to the CUP1
sequences in the second exon. The CUP1 primer sequence is
5¢-GGCACTCATGACCTTCATTTTGG.
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KH domain RNA-binding motif (29) and can speci®cally bind
RNA that contains a Mer1p enhancer element (30). Several
®ndings support a function for Mer1p at the very ®rst stage of
spliceosome assembly when the U1 snRNP binds to premRNA to form CC1. First, all natural Mer1p-activated introns
possess weak 5¢ splice sites. Secondly, the role of Mer1p in
splicing of the intron in the MER2 gene can be bypassed by a
mutant U1 snRNA that can form additional base pairs to the 5¢
splice site sequence (31). Thirdly, Nam8p, a non-essential U1
snRNP protein that can be cross-linked to pre-mRNA near the
5¢ splice site (10,11), is required for Mer1p-activated splicing
(30,32). Fourthly, Mer1p co-immunoprecipitates U1 snRNA
(30). A reasonable hypothesis based on these data is that
Mer1p stabilizes U1 snRNP binding to pre-mRNAs that
contain the Mer1p enhancer element, thereby increasing the
ef®ciency with which they progress to productive splicing
complexes. In this paper, we provide new evidence that Mer1p
can activate splicing of pre-mRNAs with weak BPSs, and that
Mer1p function also relies on components of the U2 snRNP.
These data suggest that Mer1p may function in the formation
or stabilization of multiple splicing complexes including the
pre-spliceosome.
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Two-hybrid plasmids and assays
The construction of the U2 snRNP genes in pACT2 plasmids
has been described before (36,37). The U1 snRNP genes
NAM8, SNU71, SNU56, LUC7, YHC1 and the U2 snRNP gene
SNU17 were cloned into pACT2 by PCR amplifying the genes
from genomic DNA. The MER1 ORF or activation domain
fragment was ampli®ed by PCR and ligated in pBTM116 to
form pBTM-MER1 or pBTM-AD, which fuses the lexA DNA
binding domain to Mer1p. Colorimetric assays were performed (36,37) with strain L40 carrying pBTM and pACT2
derivatives after 3±4 days of growth on selective media.
RESULTS
The Mer1p activation domain stimulates splicing
independently of the KH domain
Based on prior work (30), we suggested that the C-terminal
KH domain of Mer1p recognizes the splicing enhancer in the
intron RNA, while the N-terminal portion of Mer1p activates

splicing. To test this, the entire Mer1p protein (CTMER1) or
just the N-terminal domain of Mer1p (CTAD for MS2 Coat +
activation domain) was fused with the MS2 bacteriophage
coat protein, which binds a small, de®ned stem±loop structure
(see Fig. 1) (35). The ability of these fusion proteins to activate
splicing of modi®ed actin pre-mRNAs that contain the Mer1p
enhancer or the MS2 operator (the MS2 Coat protein binding
site) was tested.
Consistent with the weak 5¢ splice site requirement shown
previously using the GUUCGU mutation (30), the actin 5¢
splice site mutant GUAUGU to GUAUAU (G5A) pre-mRNA
containing the Mer1p splicing enhancer can be activated by
Mer1p (Fig. 2, lane 9). Fusion of MS2 Coat to the N-terminus
of Mer1p does not prevent the MS2 Coat-Mer1p fusion from
activating splicing (lane 7). However, neither MS2 Coat
protein alone nor the Mer1p fusion protein lacking the KH
domain is able to activate splicing, presumably because
neither protein can bind the enhancer (lanes 6 and 8). If instead
of the Mer1p enhancer, the pre-mRNA contains the MS2
operator, a different result is observed. With the MS2 operator
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Figure 2. The KH domain of Mer1p can be replaced with another RNA-binding domain. Primer extension analysis was used to measure splicing of modi®ed
actin RNAs produced in vivo. Actin RNAs were expressed from a plasmid and contained a G5A 5¢ splice site mutation to reduce splicing ef®ciency and either
the Mer1p enhancer element or the MS2 operator element near the 5¢ splice site. Yeast cells also included one of the plasmids from Figure 1. Lanes 2 and 5
are replicates. The dark band between the 262 and 345 nt markers in lanes 1±5 results from a primer extension stop at the MS2 operator hairpin.
Phosphorimaging quantitation of splicing ef®ciency (percent spliced) is calculated by the formula S/(S + U) 3 100 where S = spliced and U = unspliced. The
average values for duplicate samples are reported.
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Over-expression of the N-terminal part of Mer1p
squelches Mer1p-activated splicing
If the activation domain and RNA-binding domains of Mer1p
have separable functions as suggested above, then overexpression of the N-terminal domain could have a dominantnegative effect on the activity of full-length Mer1p. A similar
phenomenon, termed squelching (38), has been useful in
dissecting the function of modular transcription factors.
Similar to transcriptional squelching, over-expression of the
Mer1p N-terminal domain squelches splicing activation by
full-length Mer1p (Fig. 3, lane 3). Essentially, no splicing
activation of AMA1 reporter pre-mRNA occurs if cells express
both Mer1p and the activation domain polypeptide. Overexpressed KH domain fragment does not squelch splicing
activation by Mer1p (lane 2). We conclude that Mer1p
activation can be inhibited in a dominant-negative fashion or
squelched by N-terminal segments of the Mer1p protein. This
suggests that activation involves the interaction of the
N-terminal domain of Mer1p with another splicing factor.
This experiment, together with that shown in Figure 2,
demonstrates that the N-terminal domain of Mer1p contains a
splicing activation function. Western blots were performed to
assess the ratios of Mer1p N-terminal domain and KH RNAbinding domain fragments to full-length Mer1p, in order to
assess the amounts of protein required for squelching.
Although all plasmids used have high copy (2m) replication
origins, the truncated proteins are expressed from the GPD
promoter, whereas the full-length Mer1p protein is expressed
from the ADH promoter. Western analysis using a polyclonal
antibody raised against recombinant Mer1p shows that all
three Mer1p-derived proteins are produced and stable in yeast
extracts. Furthermore, constructs containing the GPD promoters produce ~50- to 100-fold more protein than the ADHcontaining constructs (data not shown). Presumably the
activation domain fragment prevents full-length Mer1p from
interacting with the necessary splicing factors to stimulate
splicing.

Figure 3. Over-expression of the activation domain of Mer1p has a
dominant-negative effect on full-length Mer1p. Yeast were transformed
with a MER1 expression plasmid (pMER1) or a control plasmid lacking
MER1 (pControl). Additionally, the yeast contained the KH domain plasmid
(KH), the activation domain plasmid (AD) or a control plasmid (C) that
lacks any of the MER1 domains. Total RNA was isolated and splicing of
the AMA1 pre-mRNA was measured by primer extension on duplicate
samples. Splicing ef®ciencies for each sample are reported below each lane.

Mer1p activates the splicing of introns with mutations in
the branch point sequence
Given the above results and our previous demonstration that
the N-terminal segment of Mer1p binds the U1 snRNP (30),
we began to explore the mechanism of Mer1p activation.
Mer1p is capable of activating the splicing of introns that bear
features known to reduce the ef®ciency of 5¢ splice site
recognition, including weak 5¢ splice sites, large 5¢ exons or an
intronic splicing silencer (30,31). If Mer1p activation is
speci®c to overcoming inef®cient 5¢ splice site recognition,
then an intron with an ef®ciently recognized 5¢ splice site but a
weakly recognized branch point might be expected to be
refractory to Mer1p activation. To test this idea, we introduced
mutations to the BPS of the AMA1 intron and to a modi®ed
actin intron that contains the Mer1p enhancer element and
determined whether they could be activated by Mer1p. When
the BPS is altered from UACUAAC to UAUUAAC, splicing
ef®ciency is diminished from ~30% spliced to <1% spliced for
AMA1 reporter mRNA (Fig. 4, lanes 2 and 4). When Mer1p is
expressed, splicing of the AMA1 reporter pre-mRNA containing the mutant BPS is activated to 33% spliced (lane 3). Since
the AMA1 intron retains its splicing silencer between the 5¢
splice site and the Mer1p enhancer (30), it could be argued that
Mer1p activation could still occur by increasing 5¢ splice site
recognition. To address this possibility, introns with ef®ciently
utilized 5¢ splice sites were also tested. The AMA1 NT7-15
mutant has a disruption to the splicing silencer element that
renders the intron both ef®ciently spliced and insensitive to
further activation by Mer1p (30) (Fig. 4, lanes 5 and 6). When
the NT7-15 mutant carries the UACUAAC to UAUUAAC
mutation in the BPS, its splicing is inef®cient, but is activated
by Mer1p (Fig. 4, lanes 7 and 8). An actin intron containing a
wild-type GUAUGU 5¢ splice site and the Mer1p enhancer
element, but with a mutated BPS, can also be activated by
Mer1p, albeit to a much lower extent (data not shown). The
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in place of the Mer1p enhancer, the MS2 Coat-Mer1p fusion is
able to activate splicing (lanes 2 and 5) about as well as Mer1p
through its own enhancer (lane 9). If the KH domain is
removed from the MS2 Coat-Mer1p fusion, the resulting
polypeptide (CTAD) can still activate splicing, albeit to a
lesser extent (lane 3). The CTAD protein also lacks the
C-terminal 22 residues that follow the KH domain, and their
loss may explain why the CTAD protein does not activate
splicing to the same extent as the full-length CTMER1 protein.
Neither MS2 Coat protein nor Mer1p activates splicing of the
MS2 operator pre-mRNA (lanes 1 and 4), presumably because
MS2 Coat has no activation domain, and Mer1p cannot bind
this pre-mRNA. We conclude that the KH domain is not
essential for splicing activation and serves primarily to select
introns that have the Mer1p splicing enhancer. A bacteriophage RNA binding domain fused to the N-terminus of Mer1p
can replace the KH domain provided that an appropriate RNA
binding site is present in the intron. Thus, the N-terminal
segment of Mer1p, which has been shown to associate with U1
snRNP (30), must contain protein elements necessary for
splicing activation independent of intron recognition.
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weaker splicing activation observed for the actin BPS mutant
might be due to the much larger distance between the BPS and
enhancer in the ACT1 reporter (~240 nt) as compared with the
AMA1 reporter (~50 nt). We conclude that Mer1p activation
can be imposed on pre-mRNAs with inef®cient BPSs,
suggesting Mer1p may act at multiple points in the splicing
pathway after 5¢ splice site recognition.
BPS mutations are reported to have an effect on mRNA
export from the nucleus, since mutations in both the BPS and
the branch point binding protein Bbp1p lead to ef®cient export
of unspliced mRNA (39,40). It is possible that the UAUUAAC
BPS mutation causes ef®cient export to the cytoplasm.
Interestingly, RNA derived from reporters containing BPS
mutations in this study are less abundant than from reporters
without BPS mutations in the absence of Mer1p expression
(Fig. 4, compare sum of signal in lane 2 with that in lane 4 or
total signal in lane 6 with that in lane 8) suggesting that they
are subject to a decay process that destroys them. In addition
to activating splicing, Mer1p seems to generally increase the
abundance of RNA from the mutant BPS reporters (compare
lane 3 with 4, or lane 7 with 8). One consequence of Mer1p
action might be to prevent export of unspliced pre-mRNAs to
the cytoplasm and stabilize them in the nucleus, such that
prolonged attempts at splicing can occur. This could occur
indirectly by stabilizing the association of Bbp1p with the
branch point as seems to occur in the wild-type transcript, or
directly through Mer1p±pre-mRNA interactions. Further

Figure 5. Mer1p-activated splicing requires the U2 snRNP protein Snu17p.
Primer extension analysis of AMA1, MER2 and MER3 reporter mRNAs
from SNU17 and snu17D yeast containing a MER1 expression plasmid
(+ pMER1) or a control plasmid (±). Percent spliced is reported as the
average of several replicate samples.

studies need to be performed to determine if Mer1p has a
role in nuclear retention or stabilization of enhancer-containing pre-mRNAs.
The non-essential U2 snRNP protein Snu17p is required
for Mer1p-activated splicing
To identify splicing factors that are involved in Mer1pactivated splicing, we have been analyzing Mer1p-activated
splicing in strains of yeast deleted of non-essential genes
involved in RNA processing and export. If Mer1p can activate
splicing without the missing non-essential factor, then that
factor is not required for Mer1p splicing activation. The only
known example of a non-essential gene required for Mer1p
splicing is NAM8, also known as MRE2 (30,32). Many nonessential genes involved in RNA processing have been tested
for Mer1p-activated splicing. Other than Nam8p, none of the
known non-essential U1 snRNP and commitment complex
proteins U1A (Mud1p), Cbp20p, Cbp80p, and the accessory
protein Mud2p (30 and data not shown) are required for Mer1p
splicing activation. Surprisingly, the U2 snRNP protein
Snu17p is required for Mer1p-activated splicing (Fig. 5).
Yeast lacking Snu17p cannot activate the splicing of the
AMA1, MER2 and MER3 reporter pre-mRNAs. Loss of
Mer1p-activated splicing does not occur with the deletion of
the other non-essential U2 snRNP proteins Cus2p and U2A¢
(Lea1p) (30). Snu17p is a non-essential subunit of the
multimeric U2 snRNP-associated protein complex SF3b
(41). This complex contains several conserved, essential
splicing proteins such as Hsh155p, Hsh49p, Cus1p and Rse1p
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Figure 4. Mer1p activates splicing of introns with BPS mutations. Primer
extension analysis of splicing of various AMA1 reporter mRNAs isolated
from yeast containing a MER1 expression plasmid (+ pMER1) or a control
plasmid (±). Five micrograms of total RNA were used in each reaction. The
±BP constructs contain the C to U mutation in the third position of the BPS.
The NT7-15 construct is an AMA1 intron with alterations that disrupt the
splicing silencer at nucleotides 7±15 of the intron; it does not require Mer1p
for ef®cient splicing. The relative positions of the splicing silencer (S) and
enhancer (E) with respect to the 5¢ splice site and BPS are indicated above
the gel phosphorimage. Splicing ef®ciencies were averaged for several
replicates and are reported below each lane. U and S refer to cDNAs from
unspliced and spliced RNAs, respectively.
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Table 1. Two-hybrid results with Mer1p or the activation domain
fragment of Mer1p, and U1 or U2 snRNP proteins
Blue intensity with pBTM-MER1

Vector
NAM8
SNU56
SNU71
MER1
U1C
LUC7
MUD2
BBP
CUS1
CUS2
HSH49
HSH155
SUB2
PRP9
PRP11
prp11-1
PRP5
PRP21
SNU17

±
±
++
+++
±
±
+
+
++
±
±
±
±
±
+
++++
±
±
±
±
Blue intensity with pBTM-AD
++
+++
++++

SNU56
SNU71
PRP11

Minus signs indicate no accumulation of blue color. Plus signs indicate
development of blue color with more plus signs corresponding to darker
blue color development.

known to be required for U2 snRNP binding to pre-mRNA in
yeast and humans (42). The ability of Mer1p to activate
splicing must not only involve the U1 snRNP, but the U2
snRNP as well.
Mer1p interacts with U1 and U2 snRNP proteins
Functional requirements for Mer1p splicing activation identify
two snRNP proteins, the U1 snRNP protein Nam8p (30) and
the U2 snRNP protein Snu17p (Fig. 5). In addition, Mer1p
binds the U1 snRNP in vitro (30). To test for possible protein±
protein interactions between Mer1p and U1 and U2 snRNP
proteins we performed two-hybrid tests (Table 1). Although
Nam8p is required for Mer1p to activate splicing, there is no
detectable two-hybrid interaction between Nam8p and Mer1p.
Two essential U1 snRNP proteins, Snu71p and Snu56p, are
destabilized from the U1 snRNP when Nam8p is absent (43).
Both of these proteins give a positive signal in the two-hybrid
test with Mer1p. Mer1p also weakly interacts with the U1
snRNP protein Luc7p and two accessory splicing factors that
are thought to be part of CC2. These factors, Mud2p and
Bbp1p, have been implicated in recognizing the BPS prior to
the U2 snRNP interaction (14,15,39). Several U2 snRNP
proteins were also tested, and surprisingly, Prp11p interacts
strongly with Mer1p. Like Nam8p, Snu17p does not interact
with Mer1p even though it is required for Mer1p function. A
second U2 snRNP protein (Prp9p) that interacts with Prp11p
(44), also weakly interacts with Mer1p. This weak two-hybrid
signal between Mer1p and Prp9p may result from an
interaction that is bridged by Prp11p as opposed to a direct
interaction between Mer1p and Prp9p. The weak interactions
seen between Mer1p and Bbp1p or Mud2p may also be

indirectly mediated by Prp11p. Mud2p interacts with Prp11p
(45) and Bbp1p (13). Strong positives from the two-hybrid
analysis were repeated using a bait construct that contained the
activation domain fragment of Mer1p. The results mirrored
those obtained with the full-length Mer1p (Table 1). This
indicates that the Mer1p activation domain is the primary
mediator of the interactions observed with these splicing
factors. Even for the strong interactions noted here it is
dif®cult to know for certain whether the interactions are direct
or mediated by other proteins, however, the data are consistent
with previously published immunoprecipitation results (30).
Thus, although two-hybrid interactions do not always reliably
predict direct protein±protein interactions, these data support
the interpretation that Mer1p interacts with the U1 snRNP, as
well as with other components of both the commitment
complexes and the pre-spliceosome.

DISCUSSION
Our results indicate that Mer1p has a modular structure
containing a C-terminal RNA-binding KH domain and an
N-terminal splicing activation domain. Splicing can be
activated by the N-terminal domain of Mer1p so long as it is
connected to an RNA-binding domain and the pre-mRNA
contains the appropriate target sequence. Moreover, overexpression of the N-terminal activation domain of Mer1p has a
dominant-negative effect on full-length Mer1p, presumably
by squelching the interaction between Mer1p and its target
splicing factor(s). Several other splicing regulators from
higher eukaryotes also have modular structures, most notably
SR proteins (46). We propose that the role of the KH domain is
to select introns that have the Mer1p splicing enhancer, while
the role of the N-terminal domain is to recruit splicing factors
to the pre-mRNA.
Our results also demonstrate that Mer1p cannot activate
splicing without two non-essential proteins from U1 and U2
snRNPs, and suggest that Mer1p participates in several early
splicing complexes. The observation that Mer1p can activate
the splicing of introns containing a mutated BPS indicates that
Mer1p functions after formation of CC1, which does not
require the BPS (47). The BPS is recognized after CC1 has
formed, ®rst by two accessory proteins, Bbp1p and Mud2p to
form CC2 (13,15,45), and subsequently by the U2 snRNP to
form the pre-spliceosome (18,19,48). Our results cannot
distinguish whether splicing activation of pre-mRNAs containing the mutated BPS occurs during CC2 formation or prespliceosome formation. However, the requirement for Snu17p,
a component of the U2-associated factor SF3b, suggests that
Mer1p may act as late as the pre-spliceosome stage, when U2
and SF3b are thought to bind the pre-mRNA. If Mer1p simply
stimulated the formation of CC1 and dissociated from the
complex before the pre-spliceosome has formed, then we
would not expect a U2 snRNP protein to be required for
Mer1p-activated splicing. Lastly, two-hybrid interactions
between Mer1p and U2 snRNP proteins support the conclusion that Mer1p is a component of the pre-spliceosome. These
results help build a model for Mer1p-activated splicing that is
illustrated in Figure 6. In this model, Mer1p interacts with
components of the U1 and U2 snRNPs to increase the rate of
formation or stability of early splicing complexes and allows
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for an active spliceosome to form on enhancer-containing premRNAs.
Previously, we reported that Mer1p co-immunoprecipitates
U1 but not U2 snRNA (30). However, the work presented in
this report implicates the U2 snRNP in Mer1p-activated
splicing. The absence of any U2 snRNA in the Mer1p
immunoprecipitate may re¯ect a loose or transient association
with the U2 snRNP that does not persist after stringent
washing conditions. Salt concentrations much lower than
typically used in immunoprecipitation experiments are known
to support the reversible dissociation of SF3a and SF3b
subunits from U2 snRNA (36,49,50). In addition, accessory
splicing factors that are not integral components of snRNPs,
like Mud2p and Bbp1p, also fail to quantitatively coimmunoprecipitate snRNA even in the presence of premRNA (13). It is also possible that the epitopes on Mer1p
(mol. wt ~33 kDa) are not accessible in pre-spliceosomes
(mol. wt ~2 MDa) or other splicing complexes. Therefore, the
absence of U2 snRNA in Mer1p immunoprecipitates is not as
informative as the ®nding that Mer1p requires a U2 snRNP
protein to activate introns with weak 5¢ splice sites, or that
Mer1p can activate introns with weak BPSs.

Why are Nam8p and Snu17p required for Mer1p to
activate splicing?
Previously, we have shown that Nam8p is required for Mer1p
to activate splicing, but that Nam8p is not required for Mer1p
to co-immunoprecipitate U1 snRNA (30). Hence, it seems
unlikely that Nam8p provides a direct binding site to the U1
snRNP. Nam8p, like other U1 snRNP proteins, has been
shown to be important for splicing introns with weak 5¢ splice
sites or for pre-mRNAs lacking a 5¢ cap and can stabilize
commitment complexes (11,43). Nam8p cross-links to
nucleotides immediately downstream of the 5¢ splice site
sequence, close to where the enhancer element is found.
Without Nam8p, two essential U1 snRNP proteins are
destabilized from U1 snRNP preparations in vitro (43).
These two proteins, Snu71p and Snu56p, interact with
Mer1p by two-hybrid analysis. In the absence of Nam8p,
Mer1p associates with the U1 snRNP and might stabilize the
binding of Snu71p and Snu56p. However, Mer1p may not be
able to stabilize the resulting commitment complex without
the additional stability thought to be imparted by the Nam8p±
intron interaction (10,11). We suggest that Nam8p helps to
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Figure 6. A model summarizing interactions between Mer1p and splicing factors during the formation of early splicing complexes. In this model, Mer1p
stimulates the formation of these early splicing complexes on pre-mRNAs that contain the Mer1p splicing enhancer or prevents the dissociation of these early
splicing complexes such that spliceosome assembly can progress to the formation of an active spliceosome. Proteins that interact with Mer1p by two-hybrid
analysis are indicated by a lightning bolt between the protein and Mer1p. Thicker bolts indicate stronger two-hybrid interactions. Proteins that cross-link to
the 5¢ splice site region of pre-mRNA are indicated by a red X. Proteins required for Mer1p to activate splicing, but for which no direct physical interaction
with Mer1p can be detected, are connected to Mer1p with orange arrows. The branch point adenosine of the pre-mRNA is indicated by an A, and the
enhancer element is colored red.
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